AstraZeneca Pharma India informs about updates

28 Mar 2025 Evaluate

AstraZeneca Pharma India has informed that the company will be discontinuing with the manufacturing and marketing of the product Prolonged release Isosorbide-5-mononitrate Tablets BP 30 mg and 60 mg (Imdur) from April 1, 2025. Imdur is currently being indicated for Prophylactic treatment of angina pectoris.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8902.90 6.40 (0.07%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×